Search Results
#
Genea Biocells Announces FDA Orphan Drug Designation for GBC0905 for the Treatment of FSHD
Jun 1, 2018, 7:48 AM
Genea Biocells announced that it has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its therapeutic candidate, GBC0905,
#
Highlights of 2017 MDA Conference
May 18, 2017, 6:01 PM
Genea Biocells scientists presented work from four disease modeling projects.
#
Progress in Understanding FSHD Molecular Pathology
Mar 11, 2017, 2:13 PM
Review of a newly published paper from Davide Gabellini's group.
#
Progress Update: DUX4 activity in hESC-derived muscle
Nov 14, 2016, 10:40 AM
Final update for grant to Genea Biocells.
#
IncuCyte brings live cell imaging to Genea Biocells
Oct 28, 2016, 10:09 AM
The first application for this technology is FSHD disease modelling and drug discovery.
#
#MyotubeMike4FSHD muscle disease awareness campaign
Jul 18, 2016, 6:40 PM
Your hashtags earn money for Friends of FSH Research organization
#
First stem cell model of muscular dystrophy published
Jul 14, 2016, 6:20 PM
Implications for FSHD and therapeutic developments
#
Myotube Mike at ISSCR
Jun 17, 2016, 5:43 PM
Genea Biocells is donating to Friends for every picture of Myotube Mike tagged as #MyotubeMike4FSHD on Facebook, Twitter or Instagram.
#
Research Funding: Genea Biocells to develop next generation screening platform for FSHD
May 4, 2015, 4:04 PM
Genea Biocells will develop a validated tool for the FSHD community - and we'll test important hypotheses along the way!